On the other hand, tumor-derived inflammatory factors activate tumor-associated cells presenting specific molecules that promote tumor development, such as cadherins, selectins, integrins, CD80, and PD-L1, which undergo modifications, such as glycosylation or sialylation, to enhance or repress the interactions. The gene discussed is CD80; the disease is neoplasm.